Schneerson R - Search Results

1

"Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.

Robbins JB, Towne DW, Gotschlich EC, Schneerson R. Robbins JB, et al. Among authors: schneerson r. Lancet. 1997 Sep 20;350(9081):880-2. doi: 10.1016/S0140-6736(97)03227-3. Lancet. 1997. PMID: 9310615 Review.

2

Pertussis in developed countries.

Robbins JB, Schneerson R, Trollfors B. Robbins JB, et al. Among authors: schneerson r. Lancet. 2002 Aug 31;360(9334):657-8. doi: 10.1016/S0140-6736(02)09882-3. Lancet. 2002. PMID: 12241870 No abstract available.

3

Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, Bernardino L, Maiga MA. Robbins JB, et al. Among authors: schneerson r. Bull World Health Organ. 2003;81(10):745-50; discussion 751-5. Epub 2003 Nov 25. Bull World Health Organ. 2003. PMID: 14758435 Free PMC article.

4

A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned.

Schneerson R, Robbins JB, Taranger J, Lagergård T, Trollfors B. Schneerson R, et al. Lancet. 1996 Nov 9;348(9037):1289-92. doi: 10.1016/S0140-6736(96)05243-9. Lancet. 1996. PMID: 8909384 Review. No abstract available.

5

A rebuttal: epidemic and endemic meningococcal meningitis in sub-Saharan Africa can be prevented now by routine immunization with group A meningococcal capsular polysaccharide vaccine.

Robbins JB, Schneerson R, Gotschlich EC. Robbins JB, et al. Among authors: schneerson r. Pediatr Infect Dis J. 2000 Oct;19(10):945-53. doi: 10.1097/00006454-200010000-00001. Pediatr Infect Dis J. 2000. PMID: 11055594 Review. No abstract available.

6

Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.

Jin Z, Chu C, Robbins JB, Schneerson R. Jin Z, et al. Among authors: schneerson r. Infect Immun. 2003 Sep;71(9):5115-20. doi: 10.1128/IAI.71.9.5115-5120.2003. Infect Immun. 2003. PMID: 12933854 Free PMC article.

7

Future vaccine development at NICHD.

Robbins JB, Schneerson R. Robbins JB, et al. Among authors: schneerson r. Ann N Y Acad Sci. 2004 Dec;1038:49-59. doi: 10.1196/annals.1315.011. Ann N Y Acad Sci. 2004. PMID: 15838097

8

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.

Robbins JB, Chu C, Schneerson R. Robbins JB, et al. Among authors: schneerson r. Clin Infect Dis. 1992 Aug;15(2):346-61. doi: 10.1093/clinids/15.2.346. Clin Infect Dis. 1992. PMID: 1381621 Review.

9

Synthesis of a conjugate vaccine composed of pneumococcus type 14 capsular polysaccharide bound to pertussis toxin.

Schneerson R, Levi L, Robbins JB, Bryla DM, Schiffman G, Lagergard T. Schneerson R, et al. Infect Immun. 1992 Sep;60(9):3528-32. doi: 10.1128/iai.60.9.3528-3532.1992. Infect Immun. 1992. PMID: 1500160 Free PMC article.

10

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

Devi SJ, Robbins JB, Schneerson R. Devi SJ, et al. Among authors: schneerson r. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7175-9. doi: 10.1073/pnas.88.16.7175. Proc Natl Acad Sci U S A. 1991. PMID: 1908091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page